Kalkine Media

Retailer Reformation opens flat in market debut after pricing IPO at $15

10 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Bloom Energy Earnings Surge 680%, But AI Power Player Wavers

Nike was once China's sneaker king. Here's why its sales have fallen 30%

4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Rocket Lab Stock: Can a $266 Million Defense Deal Help It Escape SpaceX’s Shadow?

Rocket Lab shares are rising after securing a $266 million contract with the U.S. Space Force, marking the company's largest deal to date.

The 'Surprisingly Soft' Unit That Caused Danaher To Plummet

Danaher shares slide despite second-quarter earnings and revenue beats, driven by softness in its biotech unit.

General Motors is set to report earnings before the bell. Here's what Wall Street expects

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Here's what to expect when Netflix reports earnings after the bell

6 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

Costco makes silent gas change that members will love

5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

EasyJet Agrees to Castlelake’s £5.2 Billion Takeover Offer

EasyJet has agreed in principle to a multi-billion pound takeover bid from US-based investment firm Castlelake.

Wall Street Has Entirely Abandoned This Absolute $11 Billion Dividend King—Here Is the 1 Aggressive Bargain I Am Accumulating on Repeat

Nike's stock has fallen to its lowest level in over 11 years, sparking a debate over whether the company is an aggressive bargain or under too much pressure.

Rocket Lab continues buying spree by acquiring satellite company Iridium

Rocket Lab acquires satellite company Iridium in $8 billion deal

Nvidia Stock: The Next Dividend Aristocrat? (NASDAQ:NVDA)

Nvidia is positioning itself as a major U.S. dividend payer, sparking discussions about its potential as a future Dividend Aristocrat.

Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America

Eli Lilly's CEO outlines the transformative potential of GLP-1s as new oral weight-loss medications enter development.

Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial